VBI Vaccines Stock (NASDAQ: VBIV) stock price, news, charts, stock research, profile.
Open | $0.594 |
Close | $0.590 |
Volume / Avg. | 130.138K / 451.938K |
Day Range | 0.580 - 0.610 |
52 Wk Range | 0.450 - 3.470 |
Market Cap | $17.287M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 1.09% |
Days to Cover | 4.55 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of VBI Vaccines (NASDAQ: VBIV) through any online brokerage.
There are no as such competitors for VBI Vaccines.
The latest price target for VBI Vaccines (NASDAQ: VBIV) was reported by Raymond James on Thursday, April 13, 2023. The analyst firm set a price target for 6.00 expecting VBIV to rise to within 12 months (a possible 886.84% upside). 0 analyst firms have reported ratings in the last year.
The stock price for VBI Vaccines (NASDAQ: VBIV) is $0.608 last updated April 24, 2024 at 8:05 AM EDT.
There are no upcoming dividends for VBI Vaccines.
VBI Vaccines’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for VBI Vaccines.
VBI Vaccines is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.